Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of transmitted HIV drug resistance from 2005 to 2015 in Victoria, Australia: a comparison of the old and the new.

Sexual health - 1 Nov 2017

D'Costa Jodie, Gooey Megan, Richards Nicole, Sameer Rizmina, Lee Elaine, Chibo Doris

Abstract excerpt

Background Baseline genotyping is part of standard-of-care treatment. It reveals that transmitted drug resistance (TDR) continues to be important for the management of HIV infection. Attention is typically focused on determining whether resistance to the protease inhibitors (PI) and reverse transcriptase inhibitors (RTI) occurs. However, the increasing use of integrase inhibitors (INIs) raises a concern that TDR...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Resistance, Viral
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Infections

Share to Mutation

Share to Polymerase Chain Reaction

Share to Protease Inhibitors

Share to Reverse Transcriptase Inhibitors

Share to Victoria

Source

Identifiers

PMID: 28641707
DOI: 10.1071/SH16190

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of transmitted HIV drug resistance from 2005 to 2015 in Victoria, Australia: a comparison of the old and the new.PMID 28641707Read ↗

Prevalence of transmitted HIV drug resistance since the availability of highly active antiretroviral therapy.Semantic proximity Read ↗

Recent trends and patterns in HIV ‐1 transmitted drug resistance in the United KingdomSemantic proximity Read ↗

Evolution of HIV-1 Surveillance Drug Resistance Mutations Over 10 Years in New South Wales, Australia.Semantic proximity Read ↗

Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted Human Immunodeficiency Virus Type 1 Drug Resistance in a Large US Clinic Population.Semantic proximity Read ↗

HIV-1 integrase inhibitor resistance among treatment naïve patients in the West of Scotland.Semantic proximity Read ↗

Transmitted drug resistance and subtype patterns of viruses from reported new HIV diagnoses in Germany, 2017-2020.Semantic proximity Read ↗

Transmitted Drug Resistance Among Human Immunodeficiency Virus (HIV)-1 Diagnoses in the United States, 2014-2018.Semantic proximity Read ↗

Temporal Trends in HIV-1 Mutations Used for the Surveillance of Transmitted Drug Resistance.Semantic proximity Read ↗

Changes from 2000 to 2009 in the Prevalence of HIV-1 Containing Drug Resistance-Associated Mutations from Antiretroviral Therapy-Naive, HIV-1-Infected Patients in the United States.Semantic proximity Read ↗

Comparison between next-generation and Sanger-based sequencing for the detection of transmitted drug-resistance mutations among recently infected HIV-1 patients in Israel, 2000-2014.Semantic proximity Read ↗

Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update.Semantic proximity Read ↗

Increasing trend of transmitted integrase inhibitor resistance in a cohort of antiretroviral therapy-naive people living with HIVSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.